What is the latest selling price of filgotinib in the Chinese market?

Filgotinib(Filgotinib) is an innovative JAK1 inhibitor mainly used to treat immune-mediated diseases such as rheumatoid arthritis. Although the original drug of filgotinib is not yet available in the Chinese market, it has been approved in many countries and regions, and there are multiple versions of the drug available for patients to choose from. Since the original drug has not yet entered China, if patients need to use this drug, they usually need to purchase the drug overseas or obtain it through medical channels.

The price of filgotinib in overseas markets is relatively expensive. Taking the European version as an example, The price of each box of 200mg*30 tablets is approximately more than RMB 10,000 (the specific price will vary according to exchange rate fluctuations). The pricing of this drug is affected by a variety of factors, including production costs, import taxes, drug pricing policies, and other factors. Moreover, overseas drug prices are usually higher, especially original drugs and imported drugs. In some European countries and the United States, the selling price of filgotinib may vary, but the general price range remains at a high level.

Compared with the original drug, filgotinib also has a generic version on the market, and the price of generic drugs is more affordable. For example, the price of 100mg*30 tablets of filgotinib generic drug produced by a Lao pharmaceutical factory is approximately more than 900 yuan (also affected by exchange rate fluctuations). Although the price of generic drugs is lower, their ingredients are basically the same as the original drugs, and there is usually no significant difference in efficacy and safety. However, it is necessary to confirm the quality and source of the medicine when purchasing to ensure the patient's therapeutic effect.

Currently, filgotinib has not been included in the medical insurance catalog in China, which means that patients may need to pay for the drug in full out of pocket when using it. For some patients who need to use the drug for a long time, the price of the drug will undoubtedly be a major burden on the treatment plan.

Reference materials:https://go.drugbank.com/drugs/DB14845